Gallium as a potential candidate for treatment of osteoporosis

Drug Discovery Today

Volumn 17, Issue 19-20, 2012, Pages 1127-1132

  Verron, E ^a,b   Bouler, J M ^b   Scimeca, J C ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM;

BONE TISSUE; DRUG BIOAVAILABILITY; DRUG MECHANISM; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; REVIEW;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; GALLIUM; HUMANS; OSTEOCLASTS; OSTEOPOROSIS;

EID: 84866743960     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.06.007     Document Type: Review

References (61)

1. L.R. Bernstein Mechanisms of therapeutic activity for gallium Pharmacol. Rev. 50 1998 665 682
2. H.C. Dudley, and G.E. Maddox Deposition of radio gallium (Ga72) in skeletal tissues J. Pharmacol. Exp. Ther. 96 1949 224 227
3. P. Collery Gallium in cancer treatment Crit. Rev. Oncol. Hematol. 42 2002 283 296
4. D.J. Straus Gallium nitrate in the treatment of lymphoma Semin. Oncol. 30 Suppl. 5 2003 25 33
5. E.S. Casper Phase II trial of gallium nitrate in patients with advanced malignant melanoma Cancer Treat. Rep. 69 1985 1019 1020
6. J.H. Malfetano A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study Am. J. Clin. Oncol. 14 1991 349 351
7. V. Matkovic Gallium prevents adjuvant arthritis in rats and interferes with macrophage/T-cell function in the immune response Curr. Ther. Res. 50 1991 255 267
8. R.P. Warrell Jr., and R. Bockman Gallium in the treatment of hypercalcemia and bone metastasis Important Adv. Oncol. 1989 205 220
9. M.K. Samson Phase I-II clinical trial of gallium nitrate (NSC-15200) Cancer Clin. Trials 3 1980 131 136
10. R.S. Bockman, and B. Bosco Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate Semin. Arthritis Rheum. 23 1994 268 269
11. C.R. Chitambar Gallium compounds as antineoplastic agents Curr. Opin. Oncol. 16 2004 547 552
12. C.R. Chitambar Medical applications and toxicities of gallium compounds Int. J. Environ. Res. Public Health 7 2010 2337 2361
13. R.D. Hancock, and F. Marsicano Parametric correlation of formation constants in aqueous solution: ligands with large donor atoms Inorg. Chem. 19 1980 2709 2714
14. P. Benezeth Gallium speciation in aqueous solution. Experimental study and modeling. Part 2. Solubility of alpha-GaOOH in acidic solutions from 150 to 250 degrees C and hydrolysis constants of gallium (III) to 300 degrees C Geochim. Cosmochim. Acta 61 1997 1345 1357
15. W.R. Harris, and V.L. Pecoraro Thermodynamic binding constants for gallium transferrin Biochemistry 22 1983 292 299
16. L.R. Bernstein Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability Met. Based Drugs 7 2000 33 47
17. R.S. Bockman Gallium increases bone calcium and crystallite perfection of hydroxyapatite Calcif. Tissue Int. 39 1986 376 381
18. R.S. Bockman Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron X-ray microscopy Proc. Natl. Acad. Sci. U.S.A. 87 1990 4149 4153
19. R. Bockman The effects of gallium nitrate on bone resorption Semin. Oncol. 30 Suppl. 5 2003 5 12
20. M. Korbas Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite J. Biol. Inorg. Chem. 9 2004 67 76
21. T.J. Hall, and T.J. Chambers Gallium inhibits bone resorption by a direct effect on osteoclasts Bone Miner. 8 1990 211 216
22. F.R. Liewehr Effect of bisphosphonates and gallium on dentin resorption in vitro Endod. Dent. Traumatol. 11 1995 20 26
23. P. Lakatos Gallium nitrate inhibits bone resorption and collagen synthesis in neonatal mouse calvariae J. Bone Miner. Res. 6 1991 1121 1126
24. H.C. Blair Reversible inhibition of osteoclastic activity by bone-bound gallium (III) J. Cell Biochem. 48 1992 401 410
25. F.J. Shaini In vitro evaluation of the effect of freshly mixed amalgam and gallium-based alloy on the viability of primary periosteal and osteoblast cell cultures Biomaterials 21 2000 113 119
26. R. Donnelly Bone particles from gallium-treated rats are resistant to resorption in vivo Bone Miner. 12 1991 167 179
27. B.J. Foster Gallium nitrate: the second metal with clinical activity Cancer Treat. Rep. 70 1986 1311 1319
28. E. Verron Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts Br. J. Pharmacol. 159 2010 1681 1692
29. E. Verron Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes Biochem. Pharmacol. 83 2011 671 679
30. L.G. Jenis Effect of gallium nitrate in vitro and in normal rats J. Cell Biochem. 52 1993 330 336
31. P.T. Guidon Jr. Gallium nitrate regulates rat osteoblast expression of osteocalcin protein and mRNA levels J. Bone Miner. Res. 8 1993 103 112
32. R.S. Bockman Gallium nitrate increases type I collagen and fibronectin mRNA and collagen protein levels in bone and fibroblast cells J. Cell Biochem. 52 1993 396 403
33. G.K. Wakley Effects of gallium on bone in the rat J. Bone Miner. Res. 7 1992 11 19
34. L.S. Stern The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats Bone Miner. 25 1994 59 69
35. C. Li Biochemical mechanism of gallium on prevention of fatal cage-layer osteoporosis Biol. Trace Elem. Res. 134 2010 195 202
36. X. Chen, and C. Wang Activity of gallium on prevention of fatal cage-layer osteoporosis Biol. Trace Elem. Res. 132 2010 129 135
37. Whitehead, CC. and Wilson, S. (1992) Characteristics of osteopenia in hens. In: Whitehead, CC (Ed.) Bone Biology and Skeletal Disorders in Poultry, pp. 265-280
38. Z. Ma, and Q. Fu Therapeutic effect of organic gallium on ovariectomized osteopenic rats by decreased serum minerals and increased bone mineral content Biol. Trace Elem. Res. 133 2010 342 349
39. Z. Ma, and F. Qin Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats Biol. Trace Elem. Res. 134 2010 280 287
40. R.R. Crichton Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells J. Inorg. Biochem. 91 2002 9 18
41. + binding Biochemistry 32 1993 3387 3395
42. N.A. Athanasou, and J. Quinn Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function J. Clin. Pathol. 43 1990 997 1003
43. H. Palokangas Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts J. Cell Sci. 110 1997 1767 1780
44. M.T. Mulari Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake Traffic 4 2003 113 125
45. K.A. Ishii Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation Nat. Med. 15 2009 259 266
46. S. Katsumata Severe iron deficiency decreases both bone formation and bone resorption in rats J. Nutr. 139 2009 238 243
47. H.F. DeLuca Metabolism of vitamin D: current status Am. J. Clin. Nutr. 29 1976 1258 1270
48. L. Tuderman Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates Eur. J. Biochem. 80 1977 341 348
49. A.W. Harris, and R.G. Sephton Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells Cancer Res. 37 1977 3634 3638
50. S.M. Larson A transferrin-mediated uptake of gallium-67 by EMT-6 sarcoma. I. Studies in tissue culture J. Nucl. Med. 20 1979 837 842
51. J.S. Rasey Tumor cell toxicity of stable gallium nitrate: enhancement by transferrin and protection by iron Eur. J. Cancer Clin. Oncol. 18 1982 661 668
52. C.A. Luttropp Uptake of gallium-67 in transfected cells and tumors absent or enriched in the transferrin receptor J. Nucl. Med. 39 1998 1405 1411
53. M.H. Sohn Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice J. Nucl. Med. 34 1993 2135 2143
54. A. Radunovic Uptake of 26-Al and 67-Ga into brain and other tissues of normal and hypotransferrinaemic mice Biometals 10 1997 185 191
55. S. Abe The uptake mechanism of gallium-67 into hepatocytes treated with carbon tetrachloride Biol. Pharm. Bull. 30 2007 224 229
56. H.G. Bone Ten years' experience with alendronate for osteoporosis in postmenopausal women N. Engl. J. Med. 350 2004 1189 1199
57. A.M. Gallagher Fracture outcomes related to persistence and compliance with oral bisphosphonates J. Bone Miner. Res. 23 2008 1569 1575
58. V. Rabenda Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women Osteoporos. Int. 19 2008 811 818
59. E. Verron Calcium phosphate biomaterials as bone drug delivery systems: a review Drug Discov. Today 15 2010 547 552
60. E. Verron In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite Biomaterials 31 2010 7776 7784
61. C. Mellier Characterization and properties of novel gallium-doped calcium phosphate ceramics Inorg. Chem. 50 2011 8252 8260